123 related articles for article (PubMed ID: 4004989)
21. Fate of fibrinogen in human arterial intima.
Smith EB; Keen GA; Grant A; Stirk C
Arteriosclerosis; 1990; 10(2):263-75. PubMed ID: 2317160
[TBL] [Abstract][Full Text] [Related]
22. Fibrinogen breakdown, long-lasting systemic fibrinolysis, and procoagulant activation during alteplase double-bolus regimen in acute myocardial infarction.
Stangl K; Laule M; Tenckhoff B; Stangl V; Gliech V; Dübel P; Grohmann A; Melzer C; Langel J; Wernecke KD; Baumann G; Ziemer S
Am J Cardiol; 1998 Apr; 81(7):841-7. PubMed ID: 9555772
[TBL] [Abstract][Full Text] [Related]
23. Dynamic coronary fibrinolysis evaluation in patients with myocardial infarction and unstable angina by specific plasma fibrin degradation product determination.
Soria C; Soria J; Mirshahi M; Mirshahi M; Dunnica S; Boucheix C; Beaufils R; Slama R; Caen JP
Thromb Res; 1987 Feb; 45(4):383-92. PubMed ID: 3576522
[TBL] [Abstract][Full Text] [Related]
24. [Immunoenzyme determination of fibrin-fibrinogen degradation product levels in acute myocardial infarct patients].
Grinshteĭn IA; Ignashenkova GV; Kitaev MI
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):18-21. PubMed ID: 3300697
[TBL] [Abstract][Full Text] [Related]
25. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M
J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569
[TBL] [Abstract][Full Text] [Related]
26. [Content of fibrinogen degradation products, soluble fibrin and the fibrinolytic activity of blood in myocardial infarct].
Belousov IuB; Panchenko EP; Pivovarov VA; Nemiro VK
Kardiologiia; 1979 Aug; 19(8):87-91. PubMed ID: 491364
[TBL] [Abstract][Full Text] [Related]
27. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
28. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
[TBL] [Abstract][Full Text] [Related]
29. Lipids in cells of atherosclerotic and uninvolved human aorta. III. Lipid distribution in intimal sublayers.
Mukhin DN; Orekhov AN; Andreeva ER; Schindeler EM; Smirnov VN
Exp Mol Pathol; 1991 Feb; 54(1):22-30. PubMed ID: 1995317
[TBL] [Abstract][Full Text] [Related]
30. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
[TBL] [Abstract][Full Text] [Related]
31. [Serial changes in hemostatic molecular markers after urokinase therapy of acute myocardial infarction].
Goto S; Kawai Y; Watanabe K; Hori S; Abe S; Handa S; Ikeda Y
Kokyu To Junkan; 1992 Jan; 40(1):89-95. PubMed ID: 1532665
[TBL] [Abstract][Full Text] [Related]
32. The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products.
Prentice CR; Hampton KK; Grant PJ; Nelson SR; Nieuwenhuizen W; Gaffney PJ
Br J Haematol; 1993 Feb; 83(2):276-81. PubMed ID: 8457476
[TBL] [Abstract][Full Text] [Related]
33. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
Salobir B; Sabovic M; Zupan IP; Ponikvar JB
Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
[TBL] [Abstract][Full Text] [Related]
34. [Cellular composition and biochemical characteristics of the human aorta].
Andreeva ER; Tertov VV; Mukhin DN; Orekhov AN
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(2):63-71. PubMed ID: 4063084
[TBL] [Abstract][Full Text] [Related]
35. Relationship between elevated plasma levels of crosslinked fibrin degradation products (XL-FDP) and the clinical presentation of patients with myocardial infarction.
Eisenberg PR; Sherman LA; Perez J; Jaffe AS
Thromb Res; 1987 Apr; 46(1):109-20. PubMed ID: 3590109
[TBL] [Abstract][Full Text] [Related]
36. Prothrombin-related antigens in human aortic intima.
Smith EB; Crosbie L; Carey S
Semin Thromb Hemost; 1996; 22(4):347-50. PubMed ID: 8944420
[TBL] [Abstract][Full Text] [Related]
37. The relationship of soluble fibrin and cross-linked fibrin degradation products to the clinical course of myocardial infarction.
Lee LV; Ewald GA; McKenzie CR; Eisenberg PR
Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):628-33. PubMed ID: 9108774
[TBL] [Abstract][Full Text] [Related]
38. Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction.
Leibundgut G; Arai K; Orsoni A; Yin H; Scipione C; Miller ER; Koschinsky ML; Chapman MJ; Witztum JL; Tsimikas S
J Am Coll Cardiol; 2012 Apr; 59(16):1426-37. PubMed ID: 22497821
[TBL] [Abstract][Full Text] [Related]
39. Impaired fibrinolysis-inducing capacity for postinjury phenotype of cultivated human arterial and human atherosclerotic intimal smooth muscle cells.
Björkerud S
Circ Res; 1988 May; 62(5):1011-8. PubMed ID: 3359571
[TBL] [Abstract][Full Text] [Related]
40. Fibrinolysis system in patients with bronchial asthma.
Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
